Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 4.4300
- -0.2900-6.14%
Trading Dec 13 13:53 ET
39.53MMarket Cap-4.06P/E (TTM)
4.6800High4.1001Low65.80KVolume4.6800Open4.7200Pre Close288.68KTurnover0.97%Turnover RatioLossP/E (Static)8.92MShares6.156852wk High5.31P/B29.96MFloat Cap2.437752wk Low--Dividend TTM6.76MShs Float2447.9980Historical High--Div YieldTTM12.29%Amplitude0.6700Historical Low4.3870Avg Price1Lot Size
Marker Therapeutics Stock Forum
Sign in to post a comment
$Marker Therapeutics (MRKR.US)$ its been long enough for company to gather data and present. what do you say?
1
$Marker Therapeutics (MRKR.US)$ my little MRKR woke up! wondering do you have news coming 😊
2
$Marker Therapeutics (MRKR.US)$ Reuters· just
Marker Therapeutics Awarded $2 Million Grant From Nih in Support of Phase 1 Study Investigating MT-601 in Car-Relapsed Patients With Non-Hodgkin’s Lymphoma
Marker Therapeutics Awarded $2 Million Grant From Nih in Support of Phase 1 Study Investigating MT-601 in Car-Relapsed Patients With Non-Hodgkin’s Lymphoma
1
$Marker Therapeutics (MRKR.US)$
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma
Marker Therapeutics (Nasdaq: MRKR) has been awarded a $2 million grant from the NIH Small Business Innovation Research program to support the clinical investigation of MT-601 in patients with non-Hodgkin's lymphoma (NHL) who have relapsed following anti-CD19 CAR T cell therapy. The grant will fund the nation...
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma
Marker Therapeutics (Nasdaq: MRKR) has been awarded a $2 million grant from the NIH Small Business Innovation Research program to support the clinical investigation of MT-601 in patients with non-Hodgkin's lymphoma (NHL) who have relapsed following anti-CD19 CAR T cell therapy. The grant will fund the nation...
$Marker Therapeutics (MRKR.US)$ All small biotech companies sell shares on good news, why did Marker previously cancel their sale? Does anyone have any ideas or reason?
$Marker Therapeutics (MRKR.US)$ Marker Therapeutics Says 'MultiTAA-specific T Cell Therapies Demonstrate Clinical Safety and Positive Clinical Data Across Multiple Indications'![]()
8
No comment yet
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Green Dragon 2024 OP : Let’s say 2 weeks